Diagnostic value of clusterin immunostaining in hepatocellular carcinoma

BACKGROUND: Histologic distinction between well differentiated hepatocellular carcinoma (HCC) and benign hepatocellular mass lesions is a known challenge. Existing biomarkers are of limited diagnostic value. Our previous studies observed an enhanced canalicular expression pattern of clusterin (CLU)...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yuan, Liu, Fangfang, Zhou, Wendi, Zhang, Sharon, Chu, Peiguo, Lin, Fan, Wang, Hanlin L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559739/
https://www.ncbi.nlm.nih.gov/pubmed/33054843
http://dx.doi.org/10.1186/s13000-020-01041-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559739/
https://www.ncbi.nlm.nih.gov/pubmed/33054843
http://dx.doi.org/10.1186/s13000-020-01041-8

Ejemplares similares